| Market Cap | ₹381Cr |
| ROE | 2.62% |
| P/E Ratio(TTM) | 57.91 |
| EPS(TTM) | 1.23 |
| P/B Ratio | 1.33 |
| Dividend Yield | 0.00% |
| Industry P/E | 32.15 |
| Book Value | 53.52 |
| Debt to Equity | 0.48 |
| Face Value | 10 |
| Managing Director | Dr. Chandrashekhar Mainde |
| Founded | 1989 |
| NSE Symbol | ZIMLAB |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.19 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 35.18 | ||
| Wockhardt | NA (0.00%) | -428.63 | ||
| Natco Pharma | NA (0.00%) | 9.70 |